Press Release Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD 31 March 2025
Press Release Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil 31 March 2025
Press Release DeFi Technologies Inc. Announces Record 2024 Financial Results: Adjusted Revenues of C$204.4 million (US$144.8 million), Adjusted EBITDA of $116.1 million (US$80.4 million) and Adjusted Net Income of C$115.07 million (US$84 million) and Notable Strategic Developments 31 March 2025
Press Release Calamos Announces Cap Ranges of Principal Protected Bitcoin ETFs April Series on the Heels of a Successful Inaugural Launch 31 March 2025
Press Release BTQ Technologies Chief Quantum Officer Dr. Gavin Brennen to Join Fireside Chat on Quantum Funding and Policy at Quantum Industry Day in Sydney 31 March 2025
Press Release TriPost Partners with Invesco Real Estate Income Trust Inc. to Acquire Minority Equity Stake in Class-A Student Housing Community in Arizona 31 March 2025
Press Release Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study 31 March 2025
Press Release Sekur Private Data Ltd. Announces Closing of Last Tranche of its Non-Brokered Private Placement Management and Insiders Participation at 30% 31 March 2025
